Skip to main content
Caplight Logo









HebeCell

HebeCell

Private
Natick, MassachusettsHealthcare & Life Scienceshttps://hebecellcorp.com/

Last Round

Series A

Aug 31, 2021

Est. Valuation

$152.44M

Total Funding Raised

$68M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

HebeCell is a biotechnology company that develops cell-based therapeutics and manufacturing platforms for immuno-oncology and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Freemium

AI Layer

Non-AI

Keywords

off-the-shelf cell therapyiPSC-derived NK cellsallogeneic cell therapycell therapy manufacturingCDMOnatural killer cellscontract manufacturinginduced pluripotent stem cellsiPSCimmuno-oncologycell therapy platformCAR-NK3D bioreactor manufacturingnCAR technologyregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HebeCell Comparables

Compare HebeCell with similar companies based on industry and business-model similarity.

HebeCell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shoreline Biosciences
86%
Century Therapeutics
80%
Artiva
79%

HebeCell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 31, 2021
Pre SeedApr 24, 2020

HebeCell Investors

Notable investors and investment history

HebeCell investors
InvestorRounds
Falcon Creek CapitalSeries A
Fangyuan Capital (Hong Kong) LimitedSeries A
Plaisance Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 107% MoM, reaching 806.

  • Aug 31, 2021

    $53M round led by Jacobio Pharmaceuticals and Falcon Creek Capital.

HebeCell Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HebeCell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HebeCell's valuation, stock price, and market status.

Firmographic Details

HeadquartersNatick, Massachusetts
Employee Range11
Year Founded2016
Last FundingAug 31, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?